Navigation Links
BSGI Posts Higher Sensitivity than Mammography or MRI for the Detection of Ductal Carcinoma In Situ
Date:8/19/2007

nosed only after BSGI demonstrated an occult focus of radiotracer uptake in the contra lateral breast, previously undetected by mammography. There were two false negative BSGI studies.

Details about BSGI with the Dilon 6800 Gamma Camera

Breast-Specific Gamma Imaging (BSGI) performed with the Dilon 6800, is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. BSGI serves as a complementary diagnostic adjunctive procedure to mammography and ultrasound for difficult-to-diagnose patients. With BSGI, the patient receives a radioactive tracing agent that is absorbed by all the cells in the body. Cancerous cells in the breast, due to their increased rate of metabolic activity, absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as "hot spots" on the BSGI image.

BSGI is ideal for patients with mammograms that are difficult to interpret due to a variety of factors, such as: dense breast tissue, suspicious areas on a mammogram, lumps that can be felt but not seen with mammography or ultrasound, implants and breast augmentation, scarring from previous surgeries and for women with a strong positive family history of breast cancer.

About Dilon Technologies

Dilon Technologies is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; Northwestern Memorial Hospital, Chicago; and The Rose, Houston. For more information about Dilon Technologies please visit '/>"/>

SOURCE Dilon Technologies

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Data on Higher Dose of Copaxone and Data Showing Copaxone is Most Cost Effective
2. Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
3. New Clinical Study Results Indicate Higher Early Virologic Response with Celgosivir Combination Therapy in HCV Non-Responders
4. Diabetes Linked to Higher Parkinsons Risk
5. Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
6. Digital vs. Analog Mammography
7. Fast, Accurate Influenza A/B Antigen Detection
8. GSKS Pazopanib Shows Positive Results in Patients with Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Tenn. , May 29, 2015  Dr. Yair ... practice to resolve vaginal health issues often caused by menopause. ... and requires no anesthesia, received FDA clearance in 2014. Dr. ... Tennessee to offer the special fractional CO 2 ... as breast cancer survivors. In 2010 there ...
(Date:5/29/2015)... and SPARTANBURG, South Carolina ... Guardian Research Network and Molecular Health have announced a ... molecular diagnostic decision support to the majority of cancer ... Research Network will collaborate with Molecular Health to harness ... to identify cohorts from hundreds of thousands of patients ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies Ltd. ... medical technologies company, is delighted to announce its ... 31, 2015, which includes revenue for three months ... of $264,340. Revenue from advanced wound care product sales ... 2015 increased 24% to $1,742,672 compared to $1,400,065 ...
Breaking Medicine Technology:The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3
... Elekta recently received 510(k) clearance from the U.S. ... software to plan spot scanning. Spot scanning is a ... conformal dose to the tumor by using thousands of ... This approach enables Intensity Modulated Proton Therapy (IMPT). ...
... SAN DIEGO, Dec. 3, 2010 Halozyme ... company developing and commercializing products targeting the extracellular ... Frost, Ph.D., to serve as president and CEO, effective ... CEO and member of the board of directors to ...
Cached Medicine Technology:Elekta Receives FDA 510(k) Clearance for XiO Software to Plan Spot Scanning for Proton Therapy 2Halozyme Therapeutics Realigns Management 2Halozyme Therapeutics Realigns Management 3
(Date:5/29/2015)... (PRWEB) May 29, 2015 John A. ... to Cincinnati , The Department of Veterans Affairs (VA) ... Gennaro as the new director of the Cincinnati VA ... care to more than 43,000 unique Veterans annually and ... over 2,000 staff, CVAMC is a two-division campus located ...
(Date:5/29/2015)... 29, 2015 According to a recent HealthDay ... full-time workers has a substance abuse problem - the data, ... 111,500 adults with full-time jobs, revealed that 9.5% of those ... year. (1) The National Council on Alcoholism and Drug Dependence ... and an estimated 70% of the 14.8 million illicit drug ...
(Date:5/29/2015)... New York, NY (PRWEB) May 29, 2015 ... Pharmaceuticals unit have reached a confidential Risperdal lawsuit ... who allegedly developed gynecomastia due to his use ... the case had been selected for the third ... in a mass tort litigation underway in Pennsylvania’s ...
(Date:5/29/2015)... Inspire Nexus, a new social network officially launching ... many life coaches have asked, "How do I find ... to become a credentialed Coach?" , Many Life and ... long. Inspire Nexus, a social network for Coaches provides ... have experience coaching a certain number of hours, qualify ...
(Date:5/29/2015)... OncLive proudly announces the 2015 ... recognized by a panel of eminent oncologists for landmark ... Honorees will be introduced and celebrated TONIGHT at the ... 8:30-11:00 p.m. CDT at The Chicago Illuminating Company, 2110 ... recognized for groundbreaking accomplishments, in fields including translational research, ...
Breaking Medicine News(10 mins):Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 2Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 3Health News:OncLive's 2015 Giants of Cancer Care™ Awards Announced Today 4
... prefer to find out whether their partners HIV Status. This ... prevent catching the disease. The risky behavior of unprotected ... is on the rise. ,In Britain, more than ... they continue to have unprotected sex. The saliva test also ...
... Delhi High Court Wednesday held that the misuse of ambulances ... stressing that their services be availed of only by ... Justice S.N. Agrawal said: "No ambulance of any of the ... by the medical staff for their private use." ...
... she was upset when her pictures appeared in magazine articles ... that blew up, I felt terrible. It appeared that I ... thin because that's what I am, and I was thinner ... else," people.com quotes her as saying to a magazine. ...
... the malfunction of a gene causes schizophrenia and depression ... the journal Neuron. ,The researchers said their findings ... treatments for schizophrenia and depression, which have been proven ... ,In their experiments, the researchers sought to explore ...
... Indira Gandhi National Open University (IGNOU), any university set ... deemed to be university can offer distance education programme ... down by the Distance Education Council (DEC) and other ... 23, 2007 had resolved that it would not insist ...
... P.K. Sreemathi and seven others for culpable homicide not amounting ... a hospital due to infection. ,The court ... a complaint by a person regarding infant deaths at the ... were due to infection the infants contracted in the labour ...
Cached Medicine News:Health News:Unprotected Sex Among the Gays on the Rise 2Health News:Malfunction of Gene Causes Schizophrenia, Depression 2Health News:Kerala Health Minister Charged for Infant Deaths in a Hospital 2
Weight is evenly distributed by fully adjustable velcro straps that cross in the back. Adjustable back velcro keeps apron snug....
Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
The NS242 is a base level constant current Conventional Peripheral Nerve Stimulator only. It uses conventional stimulation patterns only to monitor neuromuscular blocks i.e. Single Twitch, Train of F...
Double cuff electronic tourniquet....
Medicine Products: